Login / Signup

Cytomegalovirus Colitis in a Patient with Severe Treatment Refractory Ulcerative Colitis.

Michelle M BaoJuliana M KennedyMichael Todd DolingerDavid DunkinJoanne LaiMarla C Dubinsky
Published in: Crohn's & colitis 360 (2024)
Despite our patient having multiple risk factors for developing CMV colitis, upadacitinib may have played a role when considering its known impact on the herpes family of viruses. CMV colitis should be evaluated for in any patient who presents with worsening symptoms without evidence of other infection or response to increase in therapy.
Keyphrases
  • ulcerative colitis
  • case report
  • stem cells
  • epstein barr virus
  • early onset
  • sleep quality
  • bone marrow
  • drug induced
  • diffuse large b cell lymphoma